Pharmacology, Toxicology and Pharmaceutical Science
Gefitinib
100%
Apoptosis
66%
Epidermal Growth Factor Receptor
33%
Malignant Neoplasm
33%
Heat Shock Protein 70
33%
T Cell-Mediated Cytotoxicity
33%
Anticarcinogen
22%
Protein P53
22%
Caspase 8
22%
Cytotoxicity
11%
Neoplasm
11%
Protein Tyrosine Kinase Inhibitor
11%
Biochemistry, Genetics and Molecular Biology
Gefitinib
100%
Apoptosis
66%
Cancer Cell
33%
Epidermal Growth Factor Receptor
33%
P53
22%
Caspase 8
22%
Cytotoxicity
11%
Aptitude
11%
Introspection
11%
Chemistry
Gefitinib
100%
Protein
33%
Heat
33%
Epidermal Growth Factor
33%
Antineoplastic Agent
22%
Tyrosine Kinase Inhibitor
22%
Chemical Activation
22%
Cytotoxicity
11%
Concentration
11%
Resistance
11%
Immunology and Microbiology
Apoptosis
66%
Cancer Cell
33%
P53
22%
Cells
22%
Cytotoxicity
11%
Aptitude
11%
Introspection
11%
Immunity
11%